Author(s):
Nartunai Govindarajan, Lokesh Ravichandran, Prem Kumar Chelladurai, Akansha Pandey, Vendal Murugesan, Ganji Kusuma
Email(s):
gnartunai@gmail.com
DOI:
10.52711/0974-360X.2023.00943 
Address:
*Nartunai Govindarajan, Lokesh Ravichandran, Prem Kumar Chelladurai, Akansha Pandey, Vendal Murugesan, Ganji Kusuma
Captain Srinivasa Murthy, Central Ayurveda Research Institute, CCRAS, Ministry of AYUSH, Govt. of India,
A. A. Hospital Campus, Arumbakkam, Chennai – 600 106.
*Corresponding Author
Published In:
Volume - 16,
Issue - 12,
Year - 2023
ABSTRACT:
Background: The seeds of Syzygium cumini are extensively used in Ayurveda, Siddha and Unani (ASU) systems of medicine to treat diabetes, polyuria, diarrhoea and vomiting. As per classical literatures and Ayurvedic Formularies, the seed kernel is to be used in the formulations. In practice, the food and herbal drug manufacturers are incorporating the whole seed along with testa instead of seed kernel, as such sold in raw drug market. This may leads to reduction in potency of drug in formulations. Objective: The study was carried out to confirm the Pharmacopoeial compliance for seeds of S. cumini in marketed formulations Methods: Macro-microscopic studies were carried out by following standard methods of official books. Results: Macroscopically the whole seed and seed kernel can be differentiated by colour, appearance, size and shape. Microscopically the seed kernel can be differentiated from whole seed by absence of sclereids and fibres. Conclusion: The findings will be helpful to analyse the Pharmacopoeial compliance of marketed formulations containing seeds of S.cumini and to differentiate the seed kernel from testa. The studied marketed formulations of S. cumini seeds in powdered form were found to be noncompliance with Pharmacopoeial standards, since whole seed powder along with testa was found instead of seed kernel as recommended.
Cite this article:
Nartunai Govindarajan, Lokesh Ravichandran, Prem Kumar Chelladurai, Akansha Pandey, Vendal Murugesan, Ganji Kusuma. Pharmacopoeial Compliance of Marketed Formulations containing seeds of Syzygium cumini (L.) Skeels. Research Journal of Pharmacy and Technology. 2023; 16(12):5823-7. doi: 10.52711/0974-360X.2023.00943
Cite(Electronic):
Nartunai Govindarajan, Lokesh Ravichandran, Prem Kumar Chelladurai, Akansha Pandey, Vendal Murugesan, Ganji Kusuma. Pharmacopoeial Compliance of Marketed Formulations containing seeds of Syzygium cumini (L.) Skeels. Research Journal of Pharmacy and Technology. 2023; 16(12):5823-7. doi: 10.52711/0974-360X.2023.00943 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-12-44
REFERENCES:
1. WFO. 2022; World Flora Online. Published on the Internet; http://www.worldfloraonline.org. Accessed on: 26 May 2022
2. Anonymous, The Ayurvedic Pharmacopoeia of India, Part-I, Vol.II, 1st ed. New Delhi: Govt. of India, Ministry of Health and Family welfare, Dept. of ISM &H; 1999; 54-55.
3. Anonymous, The Wealth of India, Raw Materials, Vol.-X: Sp-W, National Institute of Science Communication and Information Resources, CSIR, New Delhi, India; 1976; 100-104.
4. Sharma PV. Classical Uses of Medicinal Plants, Chaukhambha Visvabharati publishers, Varanasi. 1995; 147-148.
5. Sowrirajan M. Sarabendrar Siddha Maruthuva Sudar. Saraswathi Mahal Library, Thanjavur. 2000; 218-19 & 582.
6. Anonymous, The Ayurvedic Formulary of India, Part-I, Department of Indian system of Medicine and Homoepathy, New Delhi: The Controller of Publications. 2003; 113.
7. Murugesa mudhaliar KS. Kuppusamy mudhaliar KN. Govindhasamy mudhaliar S. Gunapadam, Meteria medica (Vegetable section), Part-I. 1969; 63.
8. Anonymous, The Unani Pharmacopoeia of India, Part-I, Vol. IV, Govt. of India, Ministry of Health and Family Welfare Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoepathy (AYUSH), New Delhi: 2007; 57-58.
9. BalyanU. SarkarB. Aqueous extraction kinetics of phenolic compounds from jamun (Syzygium cumini L.) seeds, International Journal of Food Properties, 2017; 20(2), 372-389, doi: 10.1080/10942912.2016.1163266
10. SharmaS. Mehta BK. MehtaD. NagarH. MishraA. A Review on Pharmacological Activity of Syzygium cumini Extract Using Different Solvent and their Effective Doses. International Research Journal of Pharmacy. 2012; 3(12), 54-58. doi:10.7897/2230-8407.
11. Anonymous, The Ayurvedic Pharmacopoeia of India, Part-I, Vol.VI, 1st ed. New Delhi: Govt. of India, Ministry of Health and Family welfare, Dept. of AYUSH; 2008; 233-242.
12. Wallis TE. Text Book of Pharmacognosy, 5th Edn., CBS Publishers and Distributors, New Delhi, India, 1985.
13. Eames J. Mac Daniels LH. An Introduction to Plant Anatomy. 2nd ed. London: McGraw-Hill book company INC; 1947.
14. Iyengar MA. Pharmacognosy of Powdered Crude Drugs. Manipal: Manipal Power Press; 1980; ix.
15. Sass JE. Botanical Micro technique. Calcutta: Oxford & IBH Publishing co; 1958.
16. Khare CP. Indian Medicinal plants, An Illustrated Dictionary. Springer Science Business Media, LLC, Newyork, USA. 2007; 637-638.
17. Ravi K. Sivagnanam K. Subramanian S. Anti-diabetic activity of Eugenia jambolana seed kernels on streptozotocin-induced diabetic rats. J Med Food. 2004; 7(2): 187-91.doi. 10.1089/1096620041224067.
18. Mahindrakar KV. Rathod VK.Valorization of waste Syzygium cumini seed kernels by three-phase partitioning extraction and evaluation of in vitro antioxidant and hypoglycemic potential, Preparative Biochemistry & Biotechnology, 2021; 51(10): 1036-1045. doi: 10.1080/10826068.2021.1894442
19. Sujitha K. Phani Sri A. Mohan Rao PM. Lal Mahammed SrinivasaraoK. Karuna Sree V. Preliminary Screening of Syzygium cumini and Achyranthes aspera for Their Anthelmintic Activity. Research J. Pharmacognosy and Phytochemistry 2010; 2(6): 441-445.
20. Madhavi Sahu S. Prakash Rao. In-vitro Inhibitory Activity of Medicinal Plant (Syzygium cumini Seed) against Carbohydrate Metabolizing Enzymes. Res. J. Pharmacognosy and Phytochem. 2018; 10(4): 311-319. doi: 10.5958/0975-4385.2018.00050.X
21. Nikhat F. Satyanarayana D. Suresh DK. Purohit MG. Raza H. Hamza S.M. Analgesic Activity of the Isolated Constituent Syzygium cuminii (L) skeel. Research J. Pharmacognosy and Phytochemistry. 2011; 3(4): 178-179.
22. Uswatun Khasanah, Oktavia Rahayu Adiningsih, Ernila Dewi Anggraeni, Firda Uswatul Uliyah, Annisa Intan Ramadhani, Aloysia Aprilla Dewi Saraswati, Gita Kurnia Ardiani. Phytochemical screening, Total Phenolic content and Cytotoxic Activity of Seed, Leaves, and Pulp from Syzygium cumini against Breast Cancer Cell Culture 4T1. Research Journal of Pharmacognosy and Phytochemistry. 2022; 14(3):145-9. doi: 10.52711/0975-4385.2022.00027.
23. Amutha K. Aishwarya S. Evaluation of Antibacterial and Antidiabetic Activity and Phytochemical Analysis of Syzygium cumini (l.) Skeels. Seed. Research J. Pharmacology and Pharmacodynamics. 2010; 2(5): 348-350
24. Alimuddin Saifi. Rajani Chauhan. Jaya Dwivedi. Assessment of the antidiabetic activity of Syzygium cumini (Linn.) Skeels in alloxan induced diabetic rats. Res. J. Pharmacology & Pharmacodynamics. 2016; 8(3): 91-96. doi: 10.5958/2321-5836.2016.00017.3
25. Anupam Kumar. Anu Anand Mohan. Neeta Raj Sharma. Hasibur Rehman. Antibacterial, Antioxidant analysis of Phytochemical Extracts derived from seeds of Syzygium cumini L. against Pathogenic Bacteria. Research J. Pharm. and Tech. 2017; 10(8): 2707-2712. doi: 10.5958/0974-360X.2017.00481.4.